We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Exactech, Inc. (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, is pleased to announce the...
Exactech (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, today announced that at a Special...
Professor Victor Valderrabano, MD, PhD, completes first global case Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for extremities, hip, and...
Merger with TPG Capital Now Valued at $737 Million Exactech, Inc. (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for...
System to Debut at the AAHKS Annual Meeting, Booth #908 in Dallas Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for...
Q3 Net Income $2.9 Million; Diluted EPS $0.20 Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee...
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Exactech, Inc. - EXAC PR Newswire NEW YORK, Oct. 26, 2017 NEW YORK, Oct. 26, 2017 /PRNewswire/ -- Juan Monteverde...
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that, due to its...
WEISSLAW LLP: Exactech, Inc. Acquisition May Not Be in the Best Interests of EXAC Shareholders PR Newswire NEW YORK, Oct. 24, 2017 NEW YORK, Oct. 24, 2017 /PRNewswire/ -- WeissLaw LLP is...
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Exactech PR Newswire NEW YORK, Oct. 24, 2017 NEW YORK, Oct. 24, 2017 /PRNewswire/ -- Rowley Law PLLC is investigating potential...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions